ELV — Elevance Health Income Statement
0.000.00%
Last trade - 00:00
- $124.87bn
- $145.20bn
- $171.34bn
- 69
- 45
- 94
- 79
2019 December 31st | 2020 December 31st | 2021 December 31st | R2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Total Premiums Earned | |||||
Net Investment Income | |||||
Realized & Unrealized Gains / Losses | |||||
Total Revenue | 104,260 | 121,867 | 138,639 | 156,595 | 171,340 |
Losses, Benefits, and Adjustments | |||||
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 97,529 | 114,845 | 129,916 | 148,144 | 162,595 |
Operating Profit | 6,731 | 7,022 | 8,723 | 8,451 | 8,745 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 5,985 | 6,238 | 7,925 | 7,600 | 7,715 |
Provision for Income Taxes | |||||
Net Income After Taxes | 4,807 | 4,572 | 6,095 | 5,888 | 5,991 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 4,807 | 4,572 | 6,104 | 5,894 | 5,987 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 4,807 | 4,572 | 6,104 | 5,894 | 5,987 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 18.6 | 20 | 25.4 | 24.3 | 27.7 |
Dividends per Share |